Erratum

This article refers to:

Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma

In the Review by Q Zhou, VWY Lui & W Yeo, ‘Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma’, which appeared in the October issue of Future Oncology 7(10), 1149–1167 (2011), the author for correspondence was incorrectly published as:

Qian Zhou¹, Vivian WY Lui² & Winnie Yeo^†1

¹Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China

²Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

^†Author for correspondence: Tel.: [phone] ▪ Fax: [phone] ▪ [email protected]

The correct listing should be:

Qian Zhou¹, Vivian WY Lui^†2 & Winnie Yeo¹

¹Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China

²Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

^†Author for correspondence: Tel.: [phone] ▪ Fax: [phone] ▪ [email protected]

The editors would like to apologize for any inconvenience or confusion this may have caused to our readers. The original article is available in full from http://www.tandfonline.com/doi/pdf/10.2217/fon.11.95